Wanda K Nicholson MD MPH, MBA
Professor, Obstetrics & Gynecology, University of North Carolina at Chapel Hill School of Medicine
Join to view full profile
UNC at Weaver Crossing1181 Weaver Dairy RoadChapel Hill, NC 27514
Phone+1 984-974-7005
Fax+1 919-966-6356
Dr. Nicholson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina HospitalsResidency, Obstetrics and Gynecology, 1990 - 1994
University of North Carolina at Chapel Hill School of MedicineClass of 1990
Certifications & Licensure
CA State Medical License 1994 - Present
MD State Medical License 1996 - 2027
NC State Medical License 1990 - 2023
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 1 Certification WebCIS, UNC Health Care, 2012, 2014-2017
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsCombined oral contraceptive utilization and uterine fibroid incidence: A prospective study in a cohort of African-American women.Sarah R Hoffman, Jennifer S Smith, Michele Jonsson Funk, Michael G Hudgens, Charles Poole
Plos One. 2024-01-01 - 2 citationsAnthropometric Changes During Pregnancy and Their Association with Adequacy of Gestational Weight Gain.Anna Maria Siega-Riz, Myles Faith, Wanda Nicholson, Alison Stuebe, Leah Lipsky
Current Developments in Nutrition. 2024-01-01 - 22 citationsLong-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uteri...Raymond M Anchan, James B Spies, Shuaiqi Zhang, Daniel Wojdyla, Pietro Bortoletto
American Journal of Obstetrics and Gynecology. 2023-09-01
Journal Articles
- Screening to Prevent Osteoporotic FracturesWanda Nicholson, MD, JAMA Psychiatry
Authored Content
- The Comparing Options for Management: Patient-Centered Results for Uterine Fibroids (COMPARE-UF) Registry: Rationale and DesignMay 2018
Press Mentions
Task Force Recommends Breast Cancer Screening Should Begin at Age 40May 16th, 2023- Breast Cancer Screening Should Start at Age 40, Expert Task Force SaysMay 11th, 2023
- Women Should Start Screening for Breast Cancer at Age 40 Instead of 50, New Draft Guidance SaysMay 9th, 2023
Grant Support
- Long Term Effectiveness of Uterine Sparing Fibroid TreatmentsHENRY FORD HEALTH SYSTEM2023–2027
- Long Term Effectiveness of Uterine Sparing Fibroid TreatmentsHENRY FORD HEALTH SYSTEM2023–2027
- The Role Of Inflammation And Parity On GDM And Type 2 DMNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Parity, Inflammation, Gestational, And Type 2 Diabetes MellitusNational Center For Research Resources2006–2007
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
